Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
European Heart Journal Open|April 3, 2026
Reduced postprandial lipid accumulation in circulating monocytes by olezarsen attenuates pro-inflammatory changes in hypertriglyceridemic patientsMerel C Peletier, Jordan M Kraaijenhof, Miranda Versloot, et al.Journal of the American College of Cardiology|February 18, 2017
Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-IIIRaimund Pechlaner, Sotirios Tsimikas, Xiaoke Yin, et al.Journal of Clinical Lipidology|October 16, 2018
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH studyDirk J Blom, Louis O'Dea, Andres Digenio, et al.Journal of Comparative Effectiveness Research|June 19, 2026
Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparisonHandrean Soran, Asia Sikora Kessler, Montserrat Vera-Llonch, et al.The New England Journal of Medicine|December 4, 2014
Targeting APOC3 in the familial chylomicronemia syndromeDaniel Gaudet, Diane Brisson, Karine Tremblay, et al.Journal of Clinical Lipidology|April 26, 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trialJoseph L Witztum, Daniel Gaudet, Marcello Arca, et al.Journal of Clinical Lipidology|January 16, 2026
Olezarsen reduces all-cause health services utilization and improves the treatment experience of patients with familial chylomicronemia syndromeAsia Sikora Kessler, Montserrat Vera-Llonch, Ewa Karwatowska-Prokopczuk, et al.Diabetes Care|June 9, 2016
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 DiabetesAndres Digenio, Richard L Dunbar, Veronica J Alexander, et al.The New England Journal of Medicine|April 8, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia SyndromeErik S G Stroes, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, et al.Journal of the Endocrine Society|November 29, 2019
Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical ProfilesLouis St L O'Dea, James MacDougall, Veronica J Alexander, et al.Pageof 4